Not applicableStudy completedNCT00705809What this trial is testingT-Cell Project: Epidemiologic ComponentWho this might be right forPeripheral T-Cell Lymphoma National Cancer Institute (NCI) 800
Testing effectiveness (Phase 2)WithdrawnNCT03553914What this trial is testingPLM60 for Peripheral T Cell Lymphoma (PTCL)Who this might be right forPeripheral T Cell Lymphoma Conjupro Biotherapeutics, Inc.
Not applicableEnded earlyNCT00904514What this trial is testingStudy of Previously Collected and Stored Tissue Samples From Patients Previously Enrolled in a Completed National Cancer Institute Clinical TrialWho this might be right forCancer National Institutes of Health Clinical Center (CC) 241
Testing effectiveness (Phase 2)Ended earlyNCT05879458What this trial is testingRitlecitinib in CTCLWho this might be right forCTCLMycosis FungoidesSezary Syndrome Icahn School of Medicine at Mount Sinai 7
Early research (Phase 1)Looking for participantsNCT03081910What this trial is testingAutologous T-Cells Expressing a Second Generation CAR for Treatment of T-Cell Malignancies Expressing CD5 AntigenWho this might be right forT-cell Acute Lymphoblastic LymphomaT-non-Hodgkin LymphomaT-cell Acute Lymphoblastic Leukemia Baylor College of Medicine 54
Not applicableStudy completedNCT01142674What this trial is testingT-Cell Project: Prospective Collection of Data in Patients With Peripheral T-Cell LymphomaWho this might be right forLymphoma, T-Cell, Peripheral Associazione Angela Serra per la ricerca sul cancro 1,650
Early research (Phase 1)Looking for participantsNCT05098613What this trial is testingPreliminary Safety and Tolerability of CD19x22 CAR T Cells in Adolescent and Adult R/R B-NHL PatientsWho this might be right forNon-Hodgkin LymphomaB-cell Non-Hodgkin Lymphoma (B-NHL)Mantle Cell Lymphoma (MCL)+1 more University of Colorado, Denver 68
Early research (Phase 1)Not Yet RecruitingNCT07068906What this trial is testingA Clinical Study Exploring CT1194C in Patients With Relapsed/Refractory B-cell Non-Hodgkin LymphomaWho this might be right forB-Cell Non-Hodgkin Lymphoma Institute of Hematology & Blood Diseases Hospital, China 27
Not applicableLooking for participantsNCT06600568What this trial is testingNovel Therapeutic Approach for Human T-cell MalignanciesWho this might be right forT-Cell Leukemia/Lymphoma, Adult Istituto Oncologico Veneto IRCCS 120
Not applicableLooking for participantsNCT00177268What this trial is testingBlood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis ResearchWho this might be right forCutaneous T-cell LymphomaSezary SyndromeMycosis Fungoides+2 more University of Pittsburgh 200
Testing effectiveness (Phase 2)Looking for participantsNCT06630091What this trial is testingA Phase II, Single-center, Single-arm Study Evaluating the Safety and Efficacy of Golidocitinib in the Management of Newly Diagnosed Peripheral T Cell Lymphoma Patients (GOLDEN Study) and Correlative StudyWho this might be right forPeripheral T Cell Lymphoma M.D. Anderson Cancer Center 30
Testing effectiveness (Phase 2)UnknownNCT00974324What this trial is testingEndostar Combined With CHOP Regimen as First Line Chemotherapy for Peripheral T Cell LymphomaWho this might be right forT Cell Lymphoma Fudan University 15
Testing effectiveness (Phase 2)Active Not RecruitingNCT04257578What this trial is testingAcalabrutinib and Anti-CD19 CAR T-cell Therapy for the Treatment of B-cell LymphomaWho this might be right forB-Cell Non-Hodgkin LymphomaDiffuse Large B-Cell Lymphoma, Not Otherwise SpecifiedHigh Grade B-Cell Lymphoma+5 more University of Washington 23
Testing effectiveness (Phase 2)UnknownNCT05436223What this trial is testingHuman CD19 Targeted T Cells Injection(CD19 CAR-T) Therapy for Relapsed and Refractory B-cell Non-Hodgkin's LymphomaWho this might be right forB-cell Non-Hodgkin's Lymphoma Hrain Biotechnology Co., Ltd. 100
Early research (Phase 1)Study completedNCT02342782What this trial is testingYttrium Y 90 Basiliximab and Combination Chemotherapy Before Stem Cell Transplant in Treating Patients With Mature T-cell Non-Hodgkin LymphomaWho this might be right forMature T-Cell and NK-Cell Non-Hodgkin LymphomaRecurrent Mature T- and NK-Cell Non-Hodgkin LymphomaRefractory Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma+2 more City of Hope Medical Center 20
Testing effectiveness (Phase 2)UnknownNCT03598959What this trial is testingTofacitinib Combined With Chidamide in R/R ENKTCLWho this might be right forExtranodal NK/T-cell Lymphoma Sichuan University 20
Large-scale testing (Phase 3)Study completedNCT02285062What this trial is testingEfficacy and Safety Study of Lenalidomide Plus R-CHOP Chemotherapy Versus Placebo Plus R-CHOP Chemotherapy in Untreated ABC Type Diffuse Large B-cell LymphomaWho this might be right forLymphoma, Large B-Cell, Diffuse Celgene 570
Testing effectiveness (Phase 2)UnknownNCT04831710What this trial is testingSintilimab in Combination With Chidamide in Refractory and Relapsed AITLWho this might be right forAngioimmunoblastic T-cell Lymphoma Sun Yat-sen University 83
Testing effectiveness (Phase 2)Ended earlyNCT00972842What this trial is testingLenalidomide, Vorinostat and Dexamethasone in Relapsed Patients With Peripheral T-Cell Non-Hodgkin's Lymphoma (PTCL)Who this might be right forPeripheral T-Cell Non-Hodgkin's Lymphoma Arbeitsgemeinschaft medikamentoese Tumortherapie 20
Testing effectiveness (Phase 2)Looking for participantsNCT04128072What this trial is testingAnti-CCR4 Monoclonal Antibody (Mogamulizumab) and Total Skin Electron Beam Therapy (TSEB) in Patients With Stage IB-IIB Cutaneous T-Cell LymphomaWho this might be right forStage IB-IIB Cutaneous T-Cell Lymphoma European Organisation for Research and Treatment of Cancer - EORTC 43